<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T23:05:37Z</responseDate>
  <request identifier="oai:figshare.com:article/34022183" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34022183</identifier>
        <datestamp>2026-09-29T09:00:43Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Computational approaches to predicting xenobiotic metabolism by the human gut microbiota</dc:title>
          <dc:creator>Anton S. Kolodnitsky (17271966)</dc:creator>
          <dc:creator>Alexey A. Lagunin (603926)</dc:creator>
          <dc:creator>Vladimir V. Poroikov (603927)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>ADMET</dc:subject>
          <dc:subject>drug metabolism</dc:subject>
          <dc:subject>human gut microbiota</dc:subject>
          <dc:subject>in silico</dc:subject>
          <dc:subject>machine learning</dc:subject>
          <dc:subject>PBPK</dc:subject>
          <dc:subject>personalized medicine</dc:subject>
          <dc:subject>pharmacomicrobiomics</dc:subject>
          <dc:description>&lt;p&gt;The human gut microbiota significantly influences drug pharmacokinetics and pharmacodynamics, driving interindividual variability in efficacy and toxicity. As experimental characterization of microbiome-mediated metabolism remains resource-intensive, computational prediction has emerged as an auxiliary strategy for comprehensive ADMET profiling.&lt;/p&gt; &lt;p&gt;Based on a structured literature search up to 2026, this review evaluates key computational resources: 10 databases, 6 predictive algorithms, 1 genome-scale metabolic reconstruction platform, and 3 microbiome–metabolome integration models. We analyze their specific strengths, limitations, and integration into drug discovery pipelines and personalized medicine scenarios.&lt;/p&gt; &lt;p&gt;While current &lt;i&gt;in silico&lt;/i&gt; tools robustly predict qualitative metabolic potential and responsible taxa, their application in physiologically based pharmacokinetic modeling is hindered by data limitations. Training datasets exhibit a profound bias toward isolated &lt;i&gt;in vitro&lt;/i&gt; screening, alongside a critical lack of quantitative kinetic parameters. Overcoming these bottlenecks requires generating high-quality, physiologically relevant data through collaboration among computational biologists, laboratory researchers, physicians, pharmaceutical companies, and regulatory agencies. This interdisciplinary ecosystem will enable platforms that continuously learn from real-world feedback, bridging the gap between microbiome sequencing, rational drug design, and precision medicine.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T09:00:43Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.34022183.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Computational_approaches_to_predicting_xenobiotic_metabolism_by_the_human_gut_microbiota/34022183</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
